"Selective serotonin reuptake inhibitors in pediatric depression: Is the balance between benefits and risks favorable?" by Bruce Waslick, MD

Selected Works of Bruce Waslick MD

Follow Contact

Article

Selective serotonin reuptake inhibitors in pediatric depression: Is the balance between benefits and risks favorable?

All Scholarly Works

Bruce Waslick, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

2-1-2006

Abstract

Recent controversies surrounding the use of selective serotonin reuptake inhibitors (SSRIs) have highlighted the need to reassess potential benefits, as well as potential risks of this class of medications in the treatment of pediatric depression. The rec

Publication ISSN

0884-8734

Citation Information

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):11-24.